日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting PKMYT1 enhances antitumor immune responses to PD-L1 blockade in castration-resistant prostate cancer

靶向PKMYT1可增强去势抵抗性前列腺癌中PD-L1阻断的抗肿瘤免疫反应

Gao, Lin; Wang, Baozhen; Liu, Hui; Liu, Ping; Liu, Long; Han, Jingying; Wang, Xin; Dou, Baokai; Sun, Feifei; Liu, Wenyao; Wang, Xinpei; Feng, Tingting; Zhao, Ru; Yang, Xiaorong; Chen, Weiwen; Hu, Jing; Han, Bo

ZNF711 promotes enzalutamide resistance through transcriptional and epigenetic modification of the androgen receptor signaling pathway

ZNF711通过雄激素受体信号通路的转录和表观遗传修饰促进恩扎卢胺耐药性

Liu, Ping; Wang, Baozhen; Liu, Hui; Liu, Long; Sun, Feifei; Sui, Pinpin; Hu, Jing; Gao, Lin; Han, Bo

Precision Medicine Program in Chinese Pediatric Patients With Sarcoma

中国儿童肉瘤患者的精准医疗项目

Lu, Suying; Zhang, Yu; Zhang, Weiling; Huang, Junting; Yang, Chao; Wang, Juan; Gao, Ju; Guo, Xia; Yuan, Xiuli; Chen, Senmin; Sun, Feifei; Cheng, Haiyan; Yao, Wei; Dong, Kuiran; Guo, Haixia; Sun, Xiaofei; Li, Hui; Chen, Kailan; Lan, Hekui; Zhen, Zijun; Zhu, Jia; Zhang, Xiaohong; Que, Yi; Yan, Shoufang; Ma, Jingjiao; Li, Junbo; Zhu, Dongqin; Wang, Huanmin; Wang, Shan; Zhang, Yizhuo

Surface-based cortical thickness and gyrification mapping with data-driven prediction of cognitive impairment in prediabetes

基于表面皮质厚度和回旋映射的数据驱动预测糖尿病前期患者的认知障碍

Wu, Juan; Wang, Qi; Sun, Feifei; Liao, Huiying; Song, Jinhong

Epigenetic modulation with nanosatellite triggers tumoricidal immunity for hepatocellular carcinoma treatment

利用纳米卫星进行表观遗传调控可触发肿瘤杀伤免疫,用于肝细胞癌治疗。

Qu, Ying; Chen, Chen; Sun, Feifei; Liu, Shijia; Zhao, Guozhi; Zhao, Zhongxi; Liu, Chang; Jiang, Xinyi; Li, Tao

Novel multifunctional targeted nanozyme as an ultrasound contrast agent for real-time monitoring and treatment of congenital hydronephrosis renal fibrosis.

新型多功能靶向纳米酶作为超声造影剂,用于实时监测和治疗先天性肾积水肾纤维化

Zhao Qian, Zhang Di, Chen Keyan, Sun Feifei, Chen Yixin

Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial

安罗替尼治疗高危、复发或难治性肉瘤患儿的安全性和可行性:一项开放标签、单中心、单臂 Ia/Ib 期试验

Lu, Suying; Que, Yi; Liu, Dongyang; Sun, Feifei; Yao, Xueting; Deng, Liting; Zhan, Jing; Huang, Junting; Cai, Ruiqing; Wang, Xin; Zhu, Shixing; Zhen, Zijun; Zhu, Jia; Wang, Juan; Zhang, Yizhuo

CAMK1D activates AMPK/PINK1/Parkin-dependent mitophagy to promote enzalutamide resistance in prostate cancer

CAMK1D激活AMPK/PINK1/Parkin依赖性线粒体自噬,从而促进前列腺癌对恩扎卢胺的耐药性

Sun, Feifei; Qu, Ying; Mei, Shuyu; Zhang, Lin; Shao, Xianhao; Wang, Xinpei; Liu, Shijia; Wang, Meng; Liu, Wenyao; Yang, Muyi; Hu, Jing; Shi, Benkang; Gao, Lin; Han, Bo

HO-1 modulates obesity-related renal sodium metabolism via oxidative stress and Na/K-ATPase signaling

HO-1通过氧化应激和Na/K-ATPase信号传导调节肥胖相关的肾脏钠代谢

Cai, Jiahui; Sun, Feifei; Pan, Qiaoyun; Zhao, Shasha; Sun, Yunbo; Yang, Feng; Wang, Danshu; Tan, Runyan; Liu, Weiping; Tan, Qiang; Shao, Xue; Pierre, Sandrine V; Yan, Yanling

AURKB inhibition induces rhabdomyosarcoma apoptosis and ferroptosis through NPM1/SP1/ACSL5 axis.

AURKB 抑制通过 NPM1/SP1/ACSL5 轴诱导横纹肌肉瘤细胞凋亡和铁死亡

Chen Huimou, Li Mengzhen, Zhang Yu, Song Mengjia, Que Yi, Wang Juan, Sun Feifei, Zhu Jia, Huang Junting, Liu Juan, Xu Jiaqian, Lu Suying, Zhang Yizhuo